Literature DB >> 11343775

The application of comparative genomic hybridization as an additional tool in the chromosome analysis of acute myeloid leukemia and myelodysplastic syndromes.

M H Kim1, J Stewart, C Devlin, Y T Kim, E Boyd, M Connor.   

Abstract

In acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) there are frequently complex karyotypes with multiple structurally altered chromosomes, many of which are marker chromosomes of unknown origin. The aim of this study was to apply comparative genomic hybridization (CGH) to cases of AML or MDS in transformation submitted for routine cytogenetic analysis to investigate whether this approach would yield any further information and, if possible, to predict which cases would benefit from CGH analysis. Nineteen cases with AML or MDS in transformation were analyzed. CGH revealed nine cases with gains or losses of chromosomal material. In six of these cases the chromosomal location of this material was not apparent from cytogenetic analysis especially when multiple markers were present. By using fluorescence in situ hybridization (FISH) with specific libraries for the chromosome regions that showed discordance between CGH and conventional cytogenetics, we were able to identify the chromosome location of material within the karyotype. In this group of six patients, four cases of an unbalanced translocation involving regions of chromosomes 5 and 17 were characterized. Three of these cases had additional abnormalities, including two cases with regions of amplification in which oncogenes are located (MYC, MLL) and one case with a dic(7;21)(p10;p10). In all six cases it was possible to characterize complex chromosomal aberrations such as derivative chromosomes, marker chromosomes, and ring chromosomes. This study demonstrates that CGH can detect true gain and loss of critical chromosome regions more accurately than conventional karyotyping in cases with very complex karyotypes, and can thus prove useful in predicting prognosis and pinpointing areas of the genome that require further study. Also, CGH can be a useful technique to identify the origin of marker chromosomes, and it can assist in choice of probes for confirmatory FISH, when there is no clue provided from the analysis of G-banded chromosomes.

Entities:  

Mesh:

Year:  2001        PMID: 11343775     DOI: 10.1016/s0165-4608(00)00386-1

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

Review 1.  Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia - a review.

Authors:  Erich Gebhart
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

2.  High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes.

Authors:  Christine L O'Keefe; Ramon Tiu; Lukasz P Gondek; Jennifer Powers; Karl S Theil; Matt Kalaycio; Alan Lichtin; Mikkael A Sekeres; Jaroslaw P Maciejewski
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

Review 3.  Whole genome scanning as a cytogenetic tool in hematologic malignancies.

Authors:  Jaroslaw P Maciejewski; Ghulam J Mufti
Journal:  Blood       Date:  2008-05-27       Impact factor: 22.113

Review 4.  Best Practice No 185. Cytological and molecular diagnosis of lymphoma.

Authors:  G Kocjan
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

Review 5.  Genomic analysis of acute myeloid leukemia: potential for new prognostic indicators.

Authors:  Elizabeth A Eklund
Journal:  Curr Opin Hematol       Date:  2010-03       Impact factor: 3.284

6.  Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosus.

Authors:  Namrata Singh; Pamela Traisak; Kayla A Martin; Mariana J Kaplan; Philip L Cohen; Michael F Denny
Journal:  Arthritis Res Ther       Date:  2014-08-08       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.